Page last updated: 2024-11-04

sb 202190 and Pneumococcal Infections

sb 202190 has been researched along with Pneumococcal Infections in 1 studies

4-(4-fluorophenyl)-2-(4-hydroxyphenyl)-5-(4-pyridyl)imidazole: structure given in first source; inhibits p38 MAP kinase

Pneumococcal Infections: Infections with bacteria of the species STREPTOCOCCUS PNEUMONIAE.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
N'Guessan, PD1
Hippenstiel, S1
Etouem, MO1
Zahlten, J1
Beermann, W1
Lindner, D1
Opitz, B1
Witzenrath, M1
Rosseau, S1
Suttorp, N1
Schmeck, B1

Other Studies

1 other study available for sb 202190 and Pneumococcal Infections

ArticleYear
Streptococcus pneumoniae induced p38 MAPK- and NF-kappaB-dependent COX-2 expression in human lung epithelium.
    American journal of physiology. Lung cellular and molecular physiology, 2006, Volume: 290, Issue:6

    Topics: Base Sequence; Cell Line; Cyclooxygenase 2; DNA Primers; Enzyme Induction; Enzyme Inhibitors; Gene E

2006